[go: up one dir, main page]

WO2013051938A3 - Cyclic analogs of glp-1 and glp-1 related peptides and uses thereof - Google Patents

Cyclic analogs of glp-1 and glp-1 related peptides and uses thereof Download PDF

Info

Publication number
WO2013051938A3
WO2013051938A3 PCT/NL2012/050699 NL2012050699W WO2013051938A3 WO 2013051938 A3 WO2013051938 A3 WO 2013051938A3 NL 2012050699 W NL2012050699 W NL 2012050699W WO 2013051938 A3 WO2013051938 A3 WO 2013051938A3
Authority
WO
WIPO (PCT)
Prior art keywords
glp
related peptides
cyclic analogs
relates
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NL2012/050699
Other languages
French (fr)
Other versions
WO2013051938A2 (en
Inventor
Anneke Kuipers
Louwe De Vries
Tjibbe Bosma
Rick Rink
Gert Nikolaas Moll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LanthioPep BV
Original Assignee
LanthioPep BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LanthioPep BV filed Critical LanthioPep BV
Publication of WO2013051938A2 publication Critical patent/WO2013051938A2/en
Publication of WO2013051938A3 publication Critical patent/WO2013051938A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to cyclic peptide analogs of GLP-1 or of a GLP- -related peptide, comprising at least one enzymatically formed intramolecular lysinoalanine linkage between the side chains of two amino acids. The invention also relates to methods for the preparation of such cyclic peptide analogs and to the use thereof in therapy, for example metabolic diseases, neurological or neurodegenerative diseases and cardiovascular diseases.
PCT/NL2012/050699 2011-10-07 2012-10-08 Cyclic analogs of glp-1 and glp-1 related peptides and uses thereof Ceased WO2013051938A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11184392.6A EP2578599A1 (en) 2011-10-07 2011-10-07 Cyclic analogs of GLP-1 and GLP-1 related peptides
EP11184392.6 2011-10-07

Publications (2)

Publication Number Publication Date
WO2013051938A2 WO2013051938A2 (en) 2013-04-11
WO2013051938A3 true WO2013051938A3 (en) 2013-05-30

Family

ID=47080772

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2012/050699 Ceased WO2013051938A2 (en) 2011-10-07 2012-10-08 Cyclic analogs of glp-1 and glp-1 related peptides and uses thereof

Country Status (2)

Country Link
EP (1) EP2578599A1 (en)
WO (1) WO2013051938A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3237614T3 (en) 2014-12-22 2019-09-09 Lanthiopep Bv New methods for displaying cyclic peptides on the surface of bacteriophage particles
EP3280723B1 (en) * 2015-04-08 2021-01-06 Polyphor AG Backbone-cyclized peptidomimetics
ES2968038T3 (en) 2015-12-23 2024-05-06 Univ Johns Hopkins Long-acting GLP-1R agonist as therapy for neurological and neurodegenerative conditions
CA3024479A1 (en) * 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
KR20250065720A (en) 2018-04-05 2025-05-13 썬 파마슈티칼 인더스트리스 리미티드 Novel glp-1 analogues
CN110498849A (en) * 2019-09-16 2019-11-26 南京迪维奥医药科技有限公司 A kind of main peptide chain of Suo Malu peptide and preparation method thereof
EP4170347A1 (en) * 2021-10-25 2023-04-26 3B Pharmaceuticals GmbH Gastric inhibitory peptide receptor ligands

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
WO2010071807A1 (en) * 2008-12-19 2010-06-24 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080194483A1 (en) 2003-12-12 2008-08-14 Brownlee Michael A GLP-1 (9-36) methods and compositions
CA2800389A1 (en) 2006-04-20 2007-11-01 Amgen Inc. Glp-1 compounds
WO2010118034A2 (en) 2009-04-06 2010-10-14 Board Of Regents, The University Of Texas System Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
WO2010071807A1 (en) * 2008-12-19 2010-06-24 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BAPTIST GALLWITZ ET AL: "Structure/activity characteriyation of glucagon-like peptide-1", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 225, 1 January 1994 (1994-01-01), pages 1151 - 1156, XP055052352 *
FREDENHAGEN A ET AL: "DURAMYCINS B AND C, TWO NEW LANTHIONINE CONTAINING ANTIBIOTICS AS INHIBITORS OF PHOSPHOLIPASE A2. STRUCTURAL REVISION OF DURAMYCIN AND CINNAMYCIN", JOURNAL OF ANTIBIOTICS, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION, TOKYO, JP, vol. 43, no. 11, 1 November 1990 (1990-11-01), pages 1403 - 1412, XP009072979, ISSN: 0021-8820 *
LES P MIRANDA ET AL: "Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 51, no. 9, 1 January 2008 (2008-01-01), pages 2758 - 2765, XP007909689, ISSN: 0022-2623, [retrieved on 20080415], DOI: 10.1021/JM701522B *
PARKER J C ET AL: "STRUCTURE-FUNCTION ANALYSIS OF A SERIS OF GLUCAGON-LIKE PEPTIDE-1 ANALOGS", JOURNAL OF PEPTIDE RESEARCH, BLACKWELL PUBLISHING LTD, OXFORD; GB, vol. 52, no. 5, 1 November 1998 (1998-11-01), pages 398 - 409, XP000788444, ISSN: 1397-002X *
ROBERT G WALSH ET AL: "Intramolecular cross-linking of proteins by formation of lysinoalanine or lanthionine", INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, vol. 14, 1 January 1979 (1979-01-01), pages 290 - 299, XP055052333 *

Also Published As

Publication number Publication date
WO2013051938A2 (en) 2013-04-11
EP2578599A1 (en) 2013-04-10

Similar Documents

Publication Publication Date Title
WO2013051938A3 (en) Cyclic analogs of glp-1 and glp-1 related peptides and uses thereof
WO2013084000A3 (en) Exosomes for delivery of biotherapeutics
CA2818990C (en) Designed repeat proteins binding to serum albumin
MX2023010178A (en) Anti-cd70 antibody drug conjugates.
HK1200842A1 (en) Proteins with improved half-life and other properties
WO2013000922A9 (en) Ccr2 antagonist peptides
WO2014078688A3 (en) Recombinant adenoviruses and use thereof
HK1206638A1 (en) Modified polynucleotides for the production of cosmetic proteins and peptides
WO2012031250A3 (en) Compositions for labeling nerves and methods of use
CA2889275C (en) Novel method for treating cardiac infarction using hmgb1 fragment
WO2012158965A3 (en) Improved peptide pharmaceuticals for insulin resistance
WO2013186240A3 (en) Exendin-4 peptide analogues
HK1206761A1 (en) Nutritive fragments, proteins and methods
HK1205746A1 (en) Interleukin-10 polypeptide conjugates and their uses
WO2010121023A3 (en) Peptides and aptamers for targeting of neuron or nerves
HK1202800A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
WO2010010551A3 (en) Angiopoietin derived peptides
WO2014082042A3 (en) Peptides that stimulate subcutaneous adipogenesis
AR128395A2 (en) NOVEL PEPTIDES ABLE TO INDUCE THE FORMATION OF ANTIBODIES AGAINST PCSK9
IN2014DN03213A (en)
WO2011135222A3 (en) Use of peptides as transporters intended for the internalization of molecules of interest into target cells
WO2013014677A8 (en) Matrix compositions for controlled release of peptide and polypeptide molecules
WO2011123858A3 (en) Ccn3 peptides and analogs thereof for therapeutic use
WO2012077037A3 (en) PEPTIDES THAT MODULATE COMPLEX SASPase-FLG2
WO2009138494A3 (en) Amino acid sequences directed against toll-like receptors and their use for the treatment of diseases related to toll-like receptors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12778820

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12778820

Country of ref document: EP

Kind code of ref document: A2